Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-08 Sale |
2022-11-10 08:40 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
1,116 | $232.67 | $259,660 | 6,687 (Direct) |
View |
| 2022-09-26 Sale |
2022-09-28 09:12 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
25,000 | $210.62 | $5,265,576 | 27,158 (Direct) |
View |
| 2022-09-10 Purchase |
2022-09-13 11:39 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
44 | $231.2 | $10,251 | 14,282 (Direct) |
View |
| 2022-08-03 Sale |
2022-08-05 09:52 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
32,100 | $253.94 | $8,151,449 | 52,158 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 11:54 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
2,576 | $258.4 | $665,635 | 2,678 (Direct) |
View |
| 2022-06-10 Purchase |
2022-06-14 08:46 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
42 | $242.19 | $10,174 | 14,172 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 10:24 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
2,356 | $277.11 | $652,871 | 6,605 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 10:20 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
2,449 | $277.11 | $678,642 | 5,287 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 09:46 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Williams R Sanders Director |
572 | $272.98 | $156,145 | 6,431 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-14 4:36 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Summy Amy B. EVP, Chief Marketing Officer |
249 | $262.21 | $65,290 | 250 (Direct) |
View |
| 2022-02-16 Purchase |
2022-02-18 8:46 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | NEUPERT PETER M Director |
3,500 | $263.66 | $922,815 | 10,254 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-17 3:05 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
207 | $273.98 | $56,714 | 6,605 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-17 3:03 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
207 | $273.98 | $56,714 | 5,287 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-02 Tax Withholding |
2023-02-06 3:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
206 | $254.99 | 47,480 (Direct) |
View |
| 2023-02-02 Exercise |
2023-02-06 3:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
767 | $0 | 47,480 (Direct) |
View |
| 2023-02-02 Tax Withholding |
2023-02-06 3:41 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
144 | $254.99 | 17,992 (Direct) |
View |
| 2023-02-02 Exercise |
2023-02-06 3:41 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
443 | $0 | 17,992 (Direct) |
View |
| 2023-02-02 Tax Withholding |
2023-02-06 3:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
102 | $254.99 | 21,238 (Direct) |
View |
| 2023-02-02 Exercise |
2023-02-06 3:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
297 | $0 | 21,238 (Direct) |
View |
| 2023-01-09 Option Award |
2023-01-11 1:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Pike Thomas Pres & CEO Clinical Business |
16,960 | $0 | 16,960 (Direct) |
View |
| 2022-11-07 Tax Withholding |
2022-11-08 4:27 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
894 | $233.77 | 10,520 (Direct) |
View |
| 2022-11-05 Exercise |
2022-11-08 4:27 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
2,010 | $0 | 10,520 (Direct) |
View |
| 2022-11-07 Tax Withholding |
2022-11-08 4:20 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
894 | $233.77 | 18,115 (Direct) |
View |
| 2022-11-05 Exercise |
2022-11-08 4:20 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
2,010 | $0 | 18,115 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 5:04 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
5,348 | $222.56 | 82,732 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 5:04 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
12,032 | $0 | 82,732 (Direct) |
View |
| 2022-11-01 Option Award |
2022-11-03 5:04 pm |
N/A 2024-05-10 |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
18,340 | $0 | 82,732 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 5:01 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schechter Adam H President & CEO |
893 | $222.56 | 34,612 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 5:01 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schechter Adam H President & CEO |
2,007 | $0 | 34,612 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 5:00 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
892 | $222.56 | 15,927 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 5:00 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
2,007 | $0 | 15,927 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-14 2:19 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kliphouse Kirsten Marie Director |
333 | $0 | 333 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 09:52 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
9,100 | $168.49 | 52,158 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 09:52 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
11,400 | $130.6 | 52,158 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 09:52 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
11,600 | $146.59 | 52,158 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 09:52 am |
2018-02-07 2027-02-06 |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
32,100 | $0 | 52,158 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 11:54 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
23 | $257.94 | 2,678 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 11:54 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
767 | $146.59 | 2,678 (Direct) |
View |
| 2022-08-01 Exercise |
2022-08-03 11:54 am |
2020-02-12 2029-02-11 |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
817 | $0 | 2,678 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:09 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
5,310 | $0 | 19,502 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:09 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
2,360 | $276.42 | 19,502 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:07 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
4,241 | $0 | 14,130 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:07 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
1,883 | $276.42 | 14,130 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:05 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
14,144 | $0 | 52,158 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:05 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
6,286 | $276.42 | 52,158 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:04 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
3,707 | $0 | 11,915 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:04 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
1,648 | $276.42 | 11,915 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:03 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
4,241 | $0 | 8,961 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:03 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
1,885 | $276.42 | 8,961 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:02 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,241 | $0 | 7,736 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:02 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
1,792 | $276.42 | 7,736 (Direct) |
View |
| 2022-03-27 Option Award |
2022-03-29 12:00 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
2,822 | $0 | 3,696 (Direct) |
View |
| 2022-03-28 Tax Withholding |
2022-03-29 12:00 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
915 | $276.42 | 3,696 (Direct) |
View |
| 2022-03-25 Exercise |
2022-03-29 09:47 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wengel Kathryn E Director |
603 | $0 | 1,345 (Direct) |
View |
| 2022-02-11 Option Award(A) |
2022-02-15 8:29 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Williams R Sanders Director |
742 | $0 | 742 (Direct) |
View |
| 2022-02-12 Exercise |
2022-02-15 4:51 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
867 | $0 | 6,878 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 4:51 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
261 | $272.68 | 6,878 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:51 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
1,430 | $0 | 6,878 (Direct) |
View |
| 2022-02-12 Exercise |
2022-02-15 4:48 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
2,638 | $0 | 35,445 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 4:48 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
778 | $272.68 | 35,445 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:48 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
5,770 | $0 | 35,445 (Direct) |
View |
| 2022-02-12 Exercise |
2022-02-15 4:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
940 | $0 | 86,352 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 4:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
277 | $272.68 | 86,352 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
9,870 | $0 | 86,352 (Direct) |
View |
| 2022-02-12 Exercise |
2022-02-15 4:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
317 | $0 | 25,081 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 4:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
108 | $272.68 | 25,081 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
6,550 | $0 | 25,081 (Direct) |
View |
| 2022-02-12 Exercise |
2022-02-15 4:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
2,708 | $0 | 28,228 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 4:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
799 | $272.68 | 28,228 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
3,970 | $0 | 28,228 (Direct) |
View |
| 2022-02-12 Exercise |
2022-02-15 4:38 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
284 | $0 | 21,050 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 4:38 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
77 | $272.68 | 21,050 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:38 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
5,770 | $0 | 21,050 (Direct) |
View |